PHARMACYTE BIOTECH, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
PHARMACYTE BIOTECH, INC. (PMCB) reported Stock Issued During Period, Value, Restricted Stock Award, Gross of $892.50 thousand for the 0-month period ending 2025-12-11, per its 10-K filed 2026-07-29.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2026-07-29
- 2025-12-11: Stock Issued During Period, Value, Restricted Stock Award, Gross 0 month $892.50K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 0 month |
|---|---|
| 2025-12-11 | $892.50K 10-K · filed 2026-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |